Astrana Health, Inc.
DE ˙ DB ˙ US03763A2078
32,20 € ↑0,80 (2,55%)
2026-06-05
DEL PRIS
SecurityDE:3AM / Astrana Health, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership295,329 shares
Latest Disclosed Value $ 7,241,467
Goldman Sachs Group Inc reports 6.15% decrease in ownership of 3AM / Astrana Health, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 295,329 shares of Astrana Health, Inc. (DE:3AM) valued at $6,142,843 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 314,691 shares of Astrana Health, Inc.. This represents a change in shares of -6.15% during the quarter. The current value of the position is $9,509,594 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ASTRANA HEALTH CMN 03763A207 295,329 -19,362 -6.15 7,241 -7.25 0.0002
2026-02-10 2025-12-31 13F ASTRANA HEALTH CMN 03763A207 314,691 -2,305 -0.73 7,807 -13.12 0.0010
2025-11-14 2025-09-30 13F ASTRANA HEALTH CMN 03763A207 316,996 120,354 61.20 8,987 83.69 0.0011
2025-08-14 2025-06-30 13F ASTRANA HEALTH CMN 03763A207 196,642 -80,634 -29.08 4,892 -43.10 0.0007
2025-06-27 2025-03-31 13F/A-2 ASTRANA HEALTH CMN 03763A207 277,276 -84,884 -23.44 8,598 -24.70 0.0014
2025-05-16 2025-03-31 13F/A-1 ASTRANA HEALTH CMN 03763A207 277,276 -84,884 8,598 0.0014
2025-05-09 2025-03-31 13F ASTRANA HEALTH CMN 03763A207 277,276 -84,884 8,598 0.0003
2025-02-11 2024-12-31 13F ASTRANA HEALTH CMN 03763A207 362,160 103,291 39.90 11,419 -23.87 0.0018
2024-11-14 2024-09-30 13F ASTRANA HEALTH CMN 03763A207 258,869 104,412 67.60 14,999 139.43 0.0024
2024-08-13 2024-06-30 13F ASTRANA HEALTH CMN 03763A207 154,457 24,125 18.51 6,265 14.47 0.0011
2024-05-15 2024-03-31 13F APOLLO MED HLDGS CMN 03763A207 130,332 -4,146 -3.08 5,473 6.25 0.0010
2024-05-14 2023-12-31 13F/A-2 APOLLO MED HLDGS CMN 03763A207 134,478 76,578 132.26 5,151 188.35 0.0009
2024-03-01 2023-12-31 13F/A-1 APOLLO MED HLDGS CMN 03763A207 134,478 5,151
2024-02-13 2023-12-31 13F APOLLO MED HLDGS CMN 03763A207 134,478 76,578 5,151 0.0009
2024-05-15 2023-09-30 13F/A-1 APOLLO MED HLDGS CMN 03763A207 57,900 -13,646 -19.07 1,786 -20.97 0.0004
2023-11-14 2023-09-30 13F APOLLO MED HLDGS CMN 03763A207 57,900 -13,646 1,786 0.0004
2024-05-14 2023-06-30 13F/A-1 APOLLO MED HLDGS CMN 03763A207 71,546 3,167 4.63 2,261 -9.35 0.0005
2023-08-15 2023-06-30 13F APOLLO MED HLDGS CMN 03763A207 71,546 3,167 2,261 0.0005
2024-05-14 2023-03-31 13F/A-1 APOLLO MED HLDGS CMN 03763A207 68,379 10,332 17.80 2,494 45.20 0.0006
2023-05-11 2023-03-31 13F APOLLO MED HLDGS CMN 03763A207 68,379 10,332 2,494 0.0005
2024-05-14 2022-12-31 13F/A-1 APOLLO MED HLDGS CMN 03763A207 58,047 17,095 41.74 1,718 171,600.00 0.0004
2023-02-13 2022-12-31 13F APOLLO MED HLDGS CMN 03763A207 58,047 17,095 1,718 0.0004
2024-05-14 2022-09-30 13F/A-1 APOLLO MED HLDGS CMN 03763A207 40,952 2,979 7.85 2 0.00 0.0004
2022-11-14 2022-09-30 13F APOLLO MED HLDGS CMN 03763A207 40,952 2,979 1,597 0.0004
2024-05-14 2022-06-30 13F/A-2 APOLLO MED HLDGS CMN 03763A207 37,973 -820 -2.11 1 -99.95 0.0004
2022-08-18 2022-06-30 13F/A-1 APOLLO MED HLDGS CMN 03763A207 37,973 -820 1,465 0.0003
2022-08-15 2022-06-30 13F APOLLO MED HLDGS CMN 03763A207 37,973 -820 1,465 0.0001
2022-05-16 2022-03-31 13F APOLLO MED HLDGS CMN 03763A207 38,793 -124,638 -76.26 1,880 -84.35 0.0004
2022-02-17 2021-12-31 13F/A-1 APOLLO MED HLDGS CMN 03763A207 163,431 20,006 13.95 12,009 -8.04 0.0024
2022-02-14 2021-12-31 13F APOLLO MED HLDGS CMN 03763A207 163,431 20,006 12,009 0.0007
2022-01-20 2021-09-30 13F/A-1 APOLLO MED HLDGS CMN 03763A207 143,425 54,992 62.18 13,059 135.13 0.0028
2021-11-10 2021-09-30 13F APOLLO MED HLDGS CMN 03763A207 143,425 54,992 13,059 0.0008
2021-08-13 2021-06-30 13F APOLLO MED HLDGS CMN 03763A207 88,433 80,847 1,065.74 5,554 2,596.12 0.0012
2021-05-17 2021-03-31 13F APOLLO MED HLDGS CMN 03763A207 7,586 -9,267 -54.99 206 -33.12 0.0001
2021-02-12 2020-12-31 13F APOLLO MED HLDGS CMN 03763A207 16,853 -492 -2.84 308 -0.96 0.0001
2020-11-13 2020-09-30 13F APOLLO MED HLDGS CMN 03763A207 17,345 -818 -4.50 311 3.67 0.0001
2020-08-12 2020-06-30 13F APOLLO MED HLDGS CMN 03763A207 18,163 -4,005 -18.07 300 4.90 0.0001
2020-05-15 2020-03-31 13F APOLLO MED HLDGS CMN 03763A207 22,168 -11,977 -35.08 286 -54.53 0.0001
2020-02-14 2019-12-31 13F APOLLO MEDICAL HLDGS CMN 03763A207 34,145 -130,752 -79.29 629 -78.35 0.0002
2019-11-14 2019-09-30 13F APOLLO MEDICAL HLDGS CMN 03763A207 164,897 164,897 2,905 0.0008
2019-05-15 2019-03-31 13F APOLLO MEDICAL HLDGS CMN 03763A207 0 -13,752 -100.00 0 -100.00
2019-02-14 2018-12-31 13F APOLLO MEDICAL HLDGS CMN 03763A207 13,752 -18,067 -56.78 273 -61.11 0.0001
2018-11-14 2018-09-30 13F APOLLO MEDICAL HLDGS CMN 03763A207 31,819 31,819 702 0.0002
2018-08-14 2018-06-30 13F APOLLO MEDICAL HLDGS CMN 03763A207 0 -13,219 -100.00 0 -100.00
2018-05-15 2018-03-31 13F APOLLO MEDICAL HLDGS CMN 03763A207 13,219 13,219 211 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.